Evidence map›Paper›PMID 34651015›Full record

ReviewFrontiers in molecular biosciences2021

RNA Splicing: A Versatile Regulatory Mechanism in Pediatric Liver Diseases.

Jian-Li Zhou, Yu-Zhen Zhao, Shan-Shan Wang, Mo-Xian Chen, Shaoming Zhou, Chen Chen

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in molecular biosciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Jian-Li ZhouDivision of Gastroenterology, Shenzhen Children's Hospital, Shenzhen, China.
Yu-Zhen ZhaoDivision of Gastroenterology, Shenzhen Children's Hospital, Shenzhen, China.
Shan-Shan WangSchool of Life Sciences and Biopharmaceutics, Guangdong Pharmaceutical University, Guangzhou, China.
Mo-Xian ChenCo-Innovation Center for Sustainable Forestry in Southern China, College of Biology and the Environment, Nanjing Forestry University, Nanjing, China.
Shaoming ZhouDivision of Gastroenterology, Shenzhen Children's Hospital, Shenzhen, China.
Chen ChenDepartment of Infectious Disease, Nanjing Second Hospital, Nanjing University of Chinese Medicine, Nanjing, China.
Shenzhen Children's Hospital · CNGuangdong Pharmaceutical University · CNNanjing Forestry University · CNNanjing Second Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

With the development of high-throughput sequencing technology, the posttranscriptional mechanism of alternative splicing is becoming better understood. From decades of studies, alternative splicing has been shown to occur in multiple tissues, including the brain, heart, testis, skeletal muscle, and liver

Indexed as

alternative splicingchildrenliver diseasenon-alcoholic fatty liver diseaseRNA sequencingsplicing-related protein

Identifiers

PMID34651015
PMCPMC8505697
OpenAlexW3203132255

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.